AR015767A1 - Un proceso para la preparacion de compuestos de 3-glioxamida-1h-indol-4-sustituidos o sales farmaceuticamente aceptables o derivados prodrogas y loscompuestos obtenidos por dicho proceso. - Google Patents
Un proceso para la preparacion de compuestos de 3-glioxamida-1h-indol-4-sustituidos o sales farmaceuticamente aceptables o derivados prodrogas y loscompuestos obtenidos por dicho proceso.Info
- Publication number
- AR015767A1 AR015767A1 ARP990101753A ARP990101753A AR015767A1 AR 015767 A1 AR015767 A1 AR 015767A1 AR P990101753 A ARP990101753 A AR P990101753A AR P990101753 A ARP990101753 A AR P990101753A AR 015767 A1 AR015767 A1 AR 015767A1
- Authority
- AR
- Argentina
- Prior art keywords
- compounds
- alkyl
- preparation
- prodroges
- glioxamida
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D209/22—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an aralkyl radical attached to the ring nitrogen atom
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Abstract
Se trata de la preparacion de 3-glioxamidas-1H-indol utiles para inhibir SPLA2 de formula (I) donde R1 se selecciona del grupo consistente de alquilo C7-20; formula II donde R10 es seleccionado del grupo consistente de halo, alquilo C7-10; alcoxi C1-10-S-(alquiloC1-10) y halo (C1-10)alquilo, y t es un numeroentero de 0 a 5 ambos inclusive y los demás sustituyentes tienen los valores descriptos en la memoria descriptiva. Ciertas 1H-indol-3-glioxamidas sonconocidas por ser inhibidores potentes y selectivos de sPL de mamíferos utiles para el tratamiento de enfermedades tales como el shock séptico, el síndrome deaflexion respiratoria, la pancreatitis, el trauma, el asma bronquial, la rinitis alérgica, la artritis reumatoide y las enfermedades relacionadas inducidas porsPLA2.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US8211098P | 1998-04-17 | 1998-04-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR015767A1 true AR015767A1 (es) | 2001-05-16 |
Family
ID=22169126
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP990101753A AR015767A1 (es) | 1998-04-17 | 1999-04-15 | Un proceso para la preparacion de compuestos de 3-glioxamida-1h-indol-4-sustituidos o sales farmaceuticamente aceptables o derivados prodrogas y loscompuestos obtenidos por dicho proceso. |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US6265591B1 (es) |
| EP (1) | EP1071663A4 (es) |
| JP (1) | JP2002512225A (es) |
| KR (1) | KR20010042741A (es) |
| CN (1) | CN1305459A (es) |
| AR (1) | AR015767A1 (es) |
| AU (1) | AU750368B2 (es) |
| BR (1) | BR9909697A (es) |
| CA (1) | CA2326515A1 (es) |
| CO (1) | CO5080803A1 (es) |
| DZ (1) | DZ2770A1 (es) |
| EA (1) | EA003582B1 (es) |
| EG (1) | EG22139A (es) |
| HK (1) | HK1039120A1 (es) |
| HR (1) | HRP20000685A2 (es) |
| HU (1) | HUP0101344A3 (es) |
| ID (1) | ID26021A (es) |
| IL (1) | IL138827A0 (es) |
| NO (1) | NO20005148L (es) |
| NZ (1) | NZ507175A (es) |
| PE (1) | PE20000430A1 (es) |
| PL (1) | PL343487A1 (es) |
| SK (1) | SK15372000A3 (es) |
| SV (1) | SV1999000043A (es) |
| TR (1) | TR200002999T2 (es) |
| WO (1) | WO1999054300A1 (es) |
| ZA (1) | ZA200005294B (es) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1071661A4 (en) * | 1998-04-17 | 2001-08-22 | Lilly Co Eli | METHOD FOR PRODUCING 4-HYDROXYINDOL, INDAZOL AND CARBAZOL COMPOUNDS |
| US6407261B1 (en) | 1998-04-17 | 2002-06-18 | Eli Lilly And Company | Process for preparing 4-hdyroxy indole, indazole and carbazole compounds |
| DE19962300A1 (de) * | 1999-12-23 | 2001-06-28 | Asta Medica Ag | Substituierte N-Benzyl-Indol-3-yl-glyoxylsäure-Derivate mit Antitumorwirkung |
| US20030225149A1 (en) * | 2002-04-30 | 2003-12-04 | Blazecka Peter G. | Process for preparing highly functionalized gamma-butyrolactams and gamma-amino acids |
| NZ624963A (en) | 2009-04-29 | 2016-07-29 | Amarin Pharmaceuticals Ie Ltd | Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same |
| AR088377A1 (es) | 2011-10-20 | 2014-05-28 | Siena Biotech Spa | Proceso para la preparacion de 6-cloro-2,3,4,9-tetrahidro-1h-carbazol-1-carboxamida y compuestos intermedios de esta |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MY112897A (en) | 1994-04-01 | 2001-10-31 | Lilly Co Eli | Ih-indole-3-glyoxylamide spla2 inhibitors |
| EP1071661A4 (en) * | 1998-04-17 | 2001-08-22 | Lilly Co Eli | METHOD FOR PRODUCING 4-HYDROXYINDOL, INDAZOL AND CARBAZOL COMPOUNDS |
-
1999
- 1999-04-14 DZ DZ990070A patent/DZ2770A1/xx active
- 1999-04-15 US US09/647,471 patent/US6265591B1/en not_active Expired - Fee Related
- 1999-04-15 PL PL99343487A patent/PL343487A1/xx not_active Application Discontinuation
- 1999-04-15 BR BR9909697-8A patent/BR9909697A/pt not_active IP Right Cessation
- 1999-04-15 AU AU35648/99A patent/AU750368B2/en not_active Ceased
- 1999-04-15 WO PCT/US1999/008332 patent/WO1999054300A1/en not_active Application Discontinuation
- 1999-04-15 EA EA200001076A patent/EA003582B1/ru not_active IP Right Cessation
- 1999-04-15 KR KR1020007011468A patent/KR20010042741A/ko not_active Application Discontinuation
- 1999-04-15 CN CN99807248A patent/CN1305459A/zh active Pending
- 1999-04-15 EP EP99917556A patent/EP1071663A4/en not_active Withdrawn
- 1999-04-15 HU HU0101344A patent/HUP0101344A3/hu unknown
- 1999-04-15 TR TR2000/02999T patent/TR200002999T2/xx unknown
- 1999-04-15 EG EG104099D patent/EG22139A/xx active
- 1999-04-15 CA CA002326515A patent/CA2326515A1/en not_active Abandoned
- 1999-04-15 SV SV1999000043A patent/SV1999000043A/es not_active Application Discontinuation
- 1999-04-15 AR ARP990101753A patent/AR015767A1/es not_active Application Discontinuation
- 1999-04-15 JP JP2000544641A patent/JP2002512225A/ja not_active Withdrawn
- 1999-04-15 ID IDW20002058A patent/ID26021A/id unknown
- 1999-04-15 NZ NZ507175A patent/NZ507175A/xx unknown
- 1999-04-15 PE PE1999000312A patent/PE20000430A1/es not_active Application Discontinuation
- 1999-04-15 SK SK1537-2000A patent/SK15372000A3/sk unknown
- 1999-04-15 IL IL13882799A patent/IL138827A0/xx unknown
- 1999-04-16 CO CO99022895A patent/CO5080803A1/es unknown
-
2000
- 2000-09-29 ZA ZA200005294A patent/ZA200005294B/en unknown
- 2000-10-13 NO NO20005148A patent/NO20005148L/no not_active Application Discontinuation
- 2000-10-17 HR HR20000685A patent/HRP20000685A2/hr not_active Application Discontinuation
-
2002
- 2002-01-23 HK HK02100522.5A patent/HK1039120A1/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ZA200005294B (en) | 2001-10-01 |
| HRP20000685A2 (en) | 2001-10-31 |
| SV1999000043A (es) | 2000-05-02 |
| CA2326515A1 (en) | 1999-10-28 |
| EG22139A (en) | 2002-08-30 |
| WO1999054300A1 (en) | 1999-10-28 |
| EA200001076A1 (ru) | 2001-04-23 |
| PE20000430A1 (es) | 2000-05-24 |
| CN1305459A (zh) | 2001-07-25 |
| PL343487A1 (en) | 2001-08-27 |
| EP1071663A1 (en) | 2001-01-31 |
| AU3564899A (en) | 1999-11-08 |
| BR9909697A (pt) | 2000-12-19 |
| NO20005148D0 (no) | 2000-10-13 |
| EA003582B1 (ru) | 2003-06-26 |
| AU750368B2 (en) | 2002-07-18 |
| IL138827A0 (en) | 2001-10-31 |
| TR200002999T2 (tr) | 2001-01-22 |
| KR20010042741A (ko) | 2001-05-25 |
| DZ2770A1 (fr) | 2003-12-01 |
| NO20005148L (no) | 2000-11-09 |
| EP1071663A4 (en) | 2002-06-19 |
| HUP0101344A2 (hu) | 2001-09-28 |
| CO5080803A1 (es) | 2001-09-25 |
| NZ507175A (en) | 2002-12-20 |
| US6265591B1 (en) | 2001-07-24 |
| HUP0101344A3 (en) | 2002-12-28 |
| ID26021A (id) | 2000-11-16 |
| JP2002512225A (ja) | 2002-04-23 |
| HK1039120A1 (zh) | 2002-04-12 |
| SK15372000A3 (sk) | 2001-08-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE602005016261D1 (de) | Substituierte arylaminderivate und verwendungsverfahren | |
| WO2002068406A3 (en) | Substituted amine derivatives and their use for the treatment of angiogenesis | |
| BRPI0409747A (pt) | novos compostos heterocìclicos úteis para tratamento de distúrbios inflamatórios e alérgicos, processo para sua preparação e composições farmacêuticas contendo estes | |
| BR0201437A (pt) | Processo para preparar derivados de 9-desoxo-9a-aza-9a-homoeritromicina a 4"-substituìdos" | |
| DE60220422D1 (de) | Substituierte pyrazoloverbindungen zur behandlung von entzündungen | |
| RS60503A (en) | Substituted alkylamine derivatives and methods of use | |
| WO2004005279A3 (en) | Substituted anthranilic amide derivatives and methods of use | |
| IS8175A (is) | Píperasín afleiður og aðferðir við notkun þeirra | |
| BR0209821A (pt) | Compostos, processo para a manufatura desses compostos, composições farmacêuticas que compreendem os mesmos, processo para o tratamento e/ou profilaxia de enfermidades e utilização dos compostos | |
| DE602004024900D1 (de) | Substituierte 2,3-dihydro-1h-isoindol-1-one derivate und anwendungsverfahren | |
| CA2534571A1 (en) | Substituted isoquinoline derivatives and methods of use | |
| SE0200730D0 (sv) | Kristallin bas av citalopram | |
| PT672031E (pt) | Dieteres de catecol como inibidores selectivos de pde iv | |
| BR0007778A (pt) | Peptidila cetonas heterocìclicas úteis como inibidores de triptase | |
| AR030056A1 (es) | Proceso para la preparacion de citalopram purificado | |
| AR015767A1 (es) | Un proceso para la preparacion de compuestos de 3-glioxamida-1h-indol-4-sustituidos o sales farmaceuticamente aceptables o derivados prodrogas y loscompuestos obtenidos por dicho proceso. | |
| BRPI0508927A (pt) | compostos úteis para o tratamento de doenças | |
| ID27509A (id) | Turunan piridin tersubstitusi-2,3 proses pembuatannya, komposisi farmasi yang mengandung senyawa tersebut, dan senyawa-antaranya | |
| AR019871A1 (es) | Una composicion farmaceutica que comprende inhibidores del factor de transcripcion nf-kb y el uso de los mismos para la manufactura de un medicamento | |
| DE602006014576D1 (de) | Zur behandlung von mit trpv1 in zusammenhang stehenden erkrankungen geeignete 2-(benzimidazol-1yl)-n-(4-phenylthiazol-2-yl)acetamidderivate | |
| NO20054067L (no) | Nye substituerte 2,3-benzodiazepinderivater. | |
| RS20060054A (en) | Substituted furochromene compounds of antiinflammatory action | |
| BRPI0211025B8 (pt) | um novo composto para o tratamento da impotência | |
| BRPI0514077A (pt) | derivados de benzilóxi como inibidores de maob | |
| AR037285A1 (es) | Sales de mandelato de derivados de tetrahidrofurano tetraciclico sustituido |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |